Anandamide and Its Role in T Cell Responses
Author Information
Author(s): Kiprina Anastasiia, Teichmann Tom, Martín Giménez Virna Margarita, Xu Wenqing, Sailer Fiona, Windbergs Maike, Manucha Walter, Weigert Andreas, Brandes Ralf P.
Primary Institution: Goethe University Frankfurt
Hypothesis
Does anandamide influence T cell programming and inflammation?
Conclusion
Anandamide reduces TH17 responses in T cells while preserving TH1 responses, suggesting its potential in managing chronic inflammation.
Supporting Evidence
- Anandamide decreases the infiltration of myeloid cells into inflamed areas.
- Anandamide increases the number of T cells at the site of inflammation.
- Anandamide alters the activation and exhaustion status of T cells.
- Anandamide inhibits TH17 responses while preserving TH1 differentiation.
Takeaway
Anandamide is a substance that helps keep some immune cells calm while letting others do their job, which might help with long-lasting inflammation.
Methodology
The study used a mouse model of acute inflammation and human primary immune cells to assess the effects of anandamide on immune cell behavior.
Potential Biases
Potential biases may arise from the use of specific animal models and human cell lines that may not represent broader populations.
Limitations
The physiological relevance of findings was primarily determined in vitro, and the study may not fully capture in vivo complexities.
Participant Demographics
Human primary immune cells were isolated from buffy coats of anonymous donors.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website